Drug treatment of epilepsy: Options and limitations
- 31 May 2009
- journal article
- review article
- Published by Elsevier BV in Epilepsy & Behavior
- Vol. 15 (1), 56-65
- https://doi.org/10.1016/j.yebeh.2009.02.030
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Modern management of epilepsy: A practical approachEpilepsy & Behavior, 2008
- Rash from Antiepileptic Drugs: Influence by Gender, Age, and Learning DisabilityEpilepsia, 2007
- The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trialThe Lancet, 2007
- The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialThe Lancet, 2007
- Idiosyncratic Adverse Reactions to Antiepileptic DrugsEpilepsia, 2007
- Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trialThe Lancet, 2005
- Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy SocietyEpilepsia, 2004
- Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New‐Onset Epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy SocietyEpilepsia, 2004
- Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugsThe Lancet Neurology, 2003
- Enzyme induction and inhibition by new antiepileptic drugs: a review of human studiesFundamental & Clinical Pharmacology, 2000